Acute viral gastroenteritis remains a major cause of morbidity in pediatric populations worldwide, with rotavirus and adenovirus being among the most prevalent etiological agents. Rapid and accurate point-of-care diagnostics are essential for timely clinical decision-making and infection control, particularly in resource-limited settings. In this study, we report the development and optimization of a dual lateral flow immunoassay (LFIA) for the simultaneous detection of rotavirus and adenovirus antigens in stool samples.
The assay employs pathogen-specific monoclonal antibodies immobilized on discrete test lines and nanoparticle-based detection conjugates to enable parallel antigen recognition within a single device. Special emphasis was placed on sample extraction buffer formulation to reduce stool viscosity and minimize matrix interference, thereby improving antigen release and assay performance. The optimized LFIA demonstrated clear visual discrimination between rotavirus-positive, adenovirus-positive, dual-positive, and negative samples within 15 minutes.
Analytical evaluation showed improved sensitivity compared to conventional single-analyte LFIA formats, while maintaining high specificity and minimal cross-reactivity. The dual-target design reduces test time, sample volume, and operational cost, offering a practical solution for rapid screening of viral gastroenteritis at the point of care.
These results highlight the potential of dual LFIA platforms as efficient diagnostic tools for simultaneous pathogen detection and support their application in clinical and field settings.
Ayan Ahmed is a Molecular Biologist and Geneticist specializing in rapid infectious disease diagnostics and molecular assay development. She is pursuing postgraduate studies at the Health and Sciences Institute, Üsküdar University in Istanbul, Turkey, where she also gained industrial biotechnology manufacturing experience in rapid lateral flow test kit production. She is also the Founder of Genexus Medical Biotech, focusing on expanding point-of-care diagnostic access in resource-limited healthcare settings. Her research on multiplex lateral flow immunoassays has been selected for presentation at international scientific forums, including the Gordon Conference, ALFC 2025 Poster Presentation conference and the Virology Africa Congress.